» Articles » PMID: 17681354

Rapid CB1 Cannabinoid Receptor Desensitization Defines the Time Course of ERK1/2 MAP Kinase Signaling

Overview
Specialties Neurology
Pharmacology
Date 2007 Aug 8
PMID 17681354
Citations 78
Authors
Affiliations
Soon will be listed here.
Abstract

Molecular mechanisms regulating the development of physiological and behavioral tolerance to cannabinoids are not well understood. Two cellular correlates implicated in the development and maintenance of tolerance are CB(1) cannabinoid receptor internalization and uncoupling of receptor signal transduction. Both processes have been proposed as mediators of tolerance because of observations that chronic Delta(9)-tetrahydrocannabinol (THC) treatment causes both region-specific decreases in CB(1) receptors and G-protein coupling in the brain. To determine the balance of these two processes in regulating CB(1) receptor signaling during sustained receptor stimulation, we evaluated the parameters affecting ERK1/2 MAP kinase activity in HEK293 cells stably expressing CB(1) receptors. CB(1) receptor stimulation by the potent CB(1) receptor agonist, CP 55,940 transiently activated ERK1/2. To determine if CB(1) receptor desensitization or internalization was responsible for the transient nature of ERK1/2 activation, we evaluated ERK1/2 phosphorylation in HEK293 cells expressing a desensitization-deficient CB(1) receptor (S426A/S430A CB(1)). Here, the duration of S426A/S430A CB(1) receptor-mediated activation of ERK1/2 was markedly prolonged relative to wild-type receptors, and was dynamically reversed by SR141716A. Interestingly, the S426A/S430A CB(1) receptor was still able to recruit betaarrestin-2, a key mediator of receptor desensitization, to the cell surface following agonist activation. In contrast to a central role for desensitization, pharmacological and genetic approaches suggested CB(1) receptor internalization is dispensable in the transient activation of ERK1/2. This study indicates that the duration of ERK1/2 activation by CB(1) receptors is regulated by receptor desensitization and underscores the importance of G-protein uncoupling in the regulation of CB(1) receptor signaling.

Citing Articles

Cannabinoids: Role in Neurological Diseases and Psychiatric Disorders.

Kumar U Int J Mol Sci. 2025; 26(1.

PMID: 39796008 PMC: 11720483. DOI: 10.3390/ijms26010152.


Comparing CB1 receptor GIRK channel responses to receptor internalization using a kinetic imaging assay.

Andersen H, Vardakas D, Lamothe J, Perault T, Walsh K, Laprairie R Sci Rep. 2024; 14(1):18314.

PMID: 39112591 PMC: 11306342. DOI: 10.1038/s41598-024-68451-2.


Potential of dietary hemp and cannabinoids to modulate immune response to enhance health and performance in animals: opportunities and challenges.

Hassan F, Liu C, Mehboob M, Bilal R, Arain M, Siddique F Front Immunol. 2023; 14:1285052.

PMID: 38111585 PMC: 10726122. DOI: 10.3389/fimmu.2023.1285052.


Mechanisms of cannabinoid tolerance.

Piscura M, Henderson-Redmond A, Barnes R, Mitra S, Guindon J, Morgan D Biochem Pharmacol. 2023; 214:115665.

PMID: 37348821 PMC: 10528043. DOI: 10.1016/j.bcp.2023.115665.


Combined non-psychoactive Cannabis components cannabidiol and β-caryophyllene reduce chronic pain via CB1 interaction in a rat spinal cord injury model.

Eeswara A, Pacheco-Spiewak A, Jergova S, Sagen J PLoS One. 2023; 18(3):e0282920.

PMID: 36913400 PMC: 10010563. DOI: 10.1371/journal.pone.0282920.


References
1.
Kouznetsova M, Kelley B, Shen M, Thayer S . Desensitization of cannabinoid-mediated presynaptic inhibition of neurotransmission between rat hippocampal neurons in culture. Mol Pharmacol. 2002; 61(3):477-85. DOI: 10.1124/mol.61.3.477. View

2.
Arttamangkul S, Torrecilla M, Kobayashi K, Okano H, Williams J . Separation of mu-opioid receptor desensitization and internalization: endogenous receptors in primary neuronal cultures. J Neurosci. 2006; 26(15):4118-25. PMC: 6673897. DOI: 10.1523/JNEUROSCI.0303-06.2006. View

3.
Howlett A, Barth F, Bonner T, Cabral G, Casellas P, Devane W . International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev. 2002; 54(2):161-202. DOI: 10.1124/pr.54.2.161. View

4.
Campbell R, Tour O, Palmer A, Steinbach P, Baird G, Zacharias D . A monomeric red fluorescent protein. Proc Natl Acad Sci U S A. 2002; 99(12):7877-82. PMC: 122988. DOI: 10.1073/pnas.082243699. View

5.
Brown S, Wager-Miller J, Mackie K . Cloning and molecular characterization of the rat CB2 cannabinoid receptor. Biochim Biophys Acta. 2002; 1576(3):255-64. DOI: 10.1016/s0167-4781(02)00341-x. View